Kidron Miriam — SEC insider filings

SEC reporting owner CIK 1409232. 19 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2021-02-08 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ORAMED PHARMACEUTICALS INC. (ORMP)Chief Scientific Officer, Director18—1 leg · 100,000 sh · $201,00032
Lifeward Ltd. (LFWD)Director1——1

Insider filings — Kidron Miriam

FiledFormIssuerReported transactionsSource
2026-11-134ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 357,000 · Grant/award (A): 242,000EDGAR
2026-09-254ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 208,125 · Grant/award (A): 209,291 · Disposition to issuer (D): 104,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 69,999 (derivative) · Disposition to issuer (D): 47,000 (derivative) · +2 moreEDGAR
2026-03-314ORAMED PHARMACEUTICALS INC. (ORMP)Tax withholding (F): 435,084 @ $3.31EDGAR
2026-03-274Lifeward Ltd. (LFWD)Grant/award (A): 7,657 @ $0EDGAR
2026-03-184ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 119,558 @ $0EDGAR
2026-01-294ORAMED PHARMACEUTICALS INC. (ORMP)Option exercise (M): 19,000 @ $0 · Option exercise (M): 19,000 (derivative) @ $0EDGAR
2026-01-214ORAMED PHARMACEUTICALS INC. (ORMP)Gift (G): 86,166 @ $0EDGAR
2026-01-054ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 121,331 @ $0 · Grant/award (A): 115,000 @ $0 · Grant/award (A): 19,000 (derivative) @ $0EDGAR
2025-02-114ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 74,000 @ $0 · Grant/award (A): 52,000 @ $0 · Grant/award (A): 66,667 @ $0EDGAR
2025-01-064ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 207,000EDGAR
2024-11-084ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 30,000EDGAR
2024-01-084ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 295,500EDGAR
2023-05-314ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 53,500EDGAR
2023-04-204ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 213,000EDGAR
2023-03-154ORAMED PHARMACEUTICALS INC. (ORMP)Sale (S): 100,000 @ $2.01EDGAR
2022-08-014ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 34,000 · Grant/award (A): 84,000EDGAR
2022-01-054ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 42,000 · Grant/award (A): 72,000 (derivative) @ $0EDGAR
2021-09-024ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 66,666EDGAR
2021-02-084ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 100,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1409232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs